Post-intensive Care unit syndrome
BehavioralPost-intensive Care unit syndrome after an intensive care unit stay for the COVID19
NCT Number: NCT04590170
The purpose of this study is to describe post-intensive care syndrome (PICS) of patients surviving to coronavirus disease 2019 (COVID19) and their rehabilitation and recovery process from hospital to home return
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Department of Rehabilitation, Institute of Rheumatology Cochin, Paris, France
The novel coronavirus, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing the COVID-19 emerged in December 2019 and was declared pandemic in March 2020.
Although the majority of reported COVID-19 cases are mild, approximatively 5% of patients require a stay in intensive care unit, with mechanical ventilation.
Post intensive care syndrome (PICS) consists of physical, cognitive and psychological dysfunctions.
Little is known about the rate and clinical presentations of PCIS among patients surviving to COVID-19.
The objective of this study is to describe the clinical manifestations of PCIS in COVID-19 patients, and their rehabilitation process until home return.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- patients with covid19 infection :
Inclusion criteria
- control group :
Exclusion criteria
Post-intensive Care unit syndrome after an intensive care unit stay for the COVID19
Spatiotemporal measurements of walking in asymptomatic participants from the general population.
Time frame: Between 10 days and 1 month after ICU's discharge
Used to measure the agitation or sedation level of a person. Range -5 to +4 - Patients group
Time frame: Between 10 days and 1 month after ICU's discharge
Yes/no - Patients group
Time frame: Between 10 days and 1 month after ICU's discharge
Yes/no - Patients group
Time frame: Between 10 days and 1 month after ICU's discharge
Yes/no - Patients group
Time frame: Between 10 days and 1 month after ICU's discharge
Yes/no - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Yes/no - Patients group
Time frame: Between 10 days and 1 month after ICU's discharge
Yes/no - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Yes/No - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Verbal and numerical scale that asks you to rate the difficulty of your breathing Patients are asked to tick the boxes that reflect their dyspnea perception best range 0-10 lesser is better - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Yes/No - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Number of breaths/per minute. - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Tracheotomy/ ambient air / OXYGEN THERAPY Other - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
measured by pulse oximetry, which provides an indirect measurement of arterial oxygenation (SaO2) based on the differential absorption of light by oxygenated and deoxygenated blood during pulsatile blood flow - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
respiratory rate breathing rate on activity - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
measured by pulse oximetry, which provides an indirect measurement of arterial oxygenation (SaO2) based on the differential absorption of light by oxygenated and deoxygenated blood during pulsatile blood flow during activity - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Yes/no drop in blood pressure that occurs when moving from a laying down (supine) position to a standing (upright) position. - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
electrocardiogram at rest - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
self-evaluation numeric verbal scales of fatigue - Patients group ranges (0-10) lesser is better
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
self-evaluation numeric verbal scales of pain ranges (0-10) lesser is better
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Yes/No small joints (wrists, fingers, toes) and large joints (shoulders, elbows, hips, knees, ankles)
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Yes/no - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Yes/no - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Yes/no - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Yes/no Localisation
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
date and result if applicable - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
motor or sensory deficits involving the upper and the lower limbs (yes/no) Anosmia Yes/no taste loss Yes/no
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
assess muscle strength from Grade 5 (normal) to Grade 0 (no visible contraction).
MRC-SS score was defined as the sum of MRC scores from six muscles in the upper and lower limbs on both sides so that the score ranged from 60 (normal) to 0 (quadriplegic).
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
The score is the amount of time (to the nearest decimal in seconds) it takes a patient to transfer from a seated to a standing position and back to sitting five times without use of arms, Equipment • Standard height chair (43-45 cm, 17-18 inches) with a backrest. If the patient cannot perform five stands to complete the test without use of arms, a score of 0 seconds should be documented.
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Designed as a rapid screening instrument for mild cognitive dysfunction. It assesses different cognitive domains: attention and concentration, executive functions, memory, language, visuoconstruction skills, conceptual thinking, calculations, and orientation. Range 0 -30 higher is better
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Total score is from a maximum of 18, higher scores indicating better performance.
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Yes/no - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Yes/no - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Yes/no - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Yes/no - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Yes/no - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Yes/no - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Yes/no - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Yes/no - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Yes/no - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Type - Patients group
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
A 14-item self-report screening scale that was originally developed to indicate the possible presence of anxiety and depressive states It contains two 7-item scales: one for anxiety and one for depression both with a score range of 0-21.
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
20-item questionnaire, corresponding to the Manual of Mental Disorders (DSM-5) symptom criteria for PTSD.
Time frame: Change between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Introduction of antidepressant drugs Type
Time frame: change between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Introduction of neuroleptic Type
Time frame: Between 10 days and 1 month after ICU's discharge
Age, sex, formal education, marital status, occupation, place of living, socio-professional category
Time frame: Between 10 days and 1 month after ICU's discharge
number of comorbidities
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Precise
Time frame: Between 10 days and 1 month after ICU's discharge
duration of COVID-19-related symptoms nature Laboratory-confirmed SARS-CoV-2 infection as determined by PCR, or other commercial or public health assay and/or CT-scan showing typical radiological findings
Time frame: Between 10 days and 1 month after ICU's discharge
number of characteristics of ongoing hospitalization (invasive ventilation, curare, others treatments )
Time frame: Between 10 days and 1 month after ICU's discharge
Pneumopathy pulmonary embolism others
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
Number of days to discharge from hospital Service of rehabilitation care hospital at home (HAH) return at home
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
complications
Time frame: Between 10 days and 1 month and 3 months and 6 months after ICU's discharge
professional activity unemployment retirement others
Time frame: 3 months and 6 months after ICU's discharge
Related to personal care (self-performance) looks at four of these tasks: transfer, bed mobility, toileting and eating. The resident's self- performance and the amount of staff support provided are evaluated for all of these tasks ranges from 0 (independent) to 4 (total dependence)
Time frame: 3 months and 6 months after ICU's discharge
Self-reported outcome measure assessing the impact of health on an individual's everyday life Patients fill out a 12-question survey which is then scored by a clinician or researcher.
Questionnaire consisting of 12 questions that measure 8 health domains to assess physical and mental health. Physical health-related domains include General Health (GH), Physical Functioning (PF), Role Physical (RP), and Body Pain (BP). Mental health-related scales include Vitality (VT), Social Functioning (SF), Role Emotional (RE), and Mental Health (MH).
Time frame: 3 months and 6 months after ICU's discharge
Sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.
Time frame: 3 months and 6 months after ICU's discharge
Inertial Sensors to Assess Gait Quality
Time frame: Inclusion
Comparison of spatio-temporal measures of walking in patients with severe Covid 19 infection to those of an age- and sex-matched sample of asymptomatic participants.
Both groups
Assistance Publique - Hôpitaux de Paris
Other
French Cohort of covid19 Patients With Post-intensive Care Syndrome : Rehabilitation From Intensive Care Unit to Home Return - Spatio-temporal Analysis of Walking Compared to Asymptomatic Participants
Acronym: COREADOM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04924881
COVID-19, Coronaviridae Infections
Shatin, Hong Kong
View Trial DetailsNCT04939506
Behavior, COVID-19
New Orleans, Louisiana, United States
View Trial DetailsNCT04705116
COVID-19, Coronaviridae Infections
Los Angeles, California, United States
View Trial DetailsNCT04497922
Behavior, COVID-19
Boston, Massachusetts, United States
View Trial Details